QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Signal Evaluation of Bisphosphonates and Atypical Femoral Fractures

Test your understanding of the concepts covered by Signal Evaluation: Bisphosphonates and Atypical Femoral Fractures.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why was direct radiographic adjudication particularly valuable in the later cohort study?

It made the study randomized It ensured that administrative fracture codes represented the specific atypical phenotype under investigation It removed the need to adjust for patient characteristics It guaranteed that every fracture was drug-induced

Question 2 of 10 Which statement most accurately distinguishes signal detection from signal evaluation?

Signal detection determines the final benefit-risk balance, whereas signal evaluation only counts reports Signal detection identifies a possible unusual pattern, whereas signal evaluation examines causality, magnitude, susceptibility, alternatives and appropriate action Signal detection applies only to spontaneous reports, whereas signal evaluation applies only to clinical trials There is no operational distinction between the two activities

Question 3 of 10 What mechanistic issue was raised by the relatively rapid decline in risk after discontinuation?

It was inconsistent with any association between bisphosphonates and fractures It was difficult to reconcile with a model based solely on the persistent physical presence of drug in bone It proved that the event was caused exclusively by glucocorticoids It demonstrated that bone remodelling stops permanently after treatment

Question 4 of 10 A patient treated with a bisphosphonate for seven years develops persistent thigh pain and imaging shows cortical thickening with an incomplete transverse subtrochanteric fracture. What is the most appropriate professional interpretation?

The case is highly compatible with the recognized atypical-fracture signal and warrants appropriate clinical investigation The case cannot be related to treatment because the fracture is incomplete The exposure is irrelevant because pain is not itself a fracture The case should be classified as a typical traumatic fracture without further assessment

Question 5 of 10 How should the Swedish study's relative risk of approximately 47.3 and an estimated excess of about 5 cases per 10,000 patient-years be communicated?

The risk was approximately 47% among treated patients The relative association was very large, but the absolute excess risk remained small because baseline incidence was low The absolute risk was too high to permit continued treatment The relative risk and absolute risk were essentially interchangeable measures

Question 6 of 10 Which sequence best describes the evolution of this pharmacovigilance signal?

Regulatory prohibition, followed by isolated reports and then mechanistic speculation Distinctive clinical observations, case series, epidemiological quantification, regulatory review and proportionate risk minimization Randomized trial detection, immediate class-wide withdrawal and later benefit assessment Administrative coding, spontaneous reporting cessation and rejection of biological plausibility

Question 7 of 10 Why can a high relative risk coexist with a favourable overall benefit-risk balance?

Relative risk measures are always clinically unimportant The adverse event may have a very low baseline incidence, while treatment prevents a larger number of clinically important osteoporotic fractures Atypical fractures are never serious A favourable benefit-risk balance means the association is not causal

Question 8 of 10 Which regulatory conclusion best reflects the article's account of the EMA assessment?

The risk was confined definitively to alendronate The event was considered likely to be a bisphosphonate class effect, while the overall benefit-risk balance remained favourable All bisphosphonate treatment was prohibited after five years The signal was rejected because the absolute risk was low

Question 9 of 10 Why does an exposure-duration relationship strengthen, but not prove, the causal hypothesis?

Longer exposure automatically excludes all confounding Increasing risk with cumulative exposure is compatible with a drug-related process, but may still reflect other correlated factors Duration-response relationships are only relevant to common events A duration relationship demonstrates that the medicine has no benefit

Question 10 of 10 In a borderline case with suggestive but incomplete imaging, what is the best next pharmacovigilance approach?

Force a definitive classification based only on treatment exposure Discard the case because uncertainty makes it unusable Seek complete imaging, specialist interpretation, exposure details and information on alternative causes Classify the event as a class effect without reviewing the individual case

Knowledge Assessment: Signal Evaluation of Bisphosphonates and Atypical Femoral Fractures

Cookie Settings